Prestige Wealth Management Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Prestige Wealth Management Group LLC
- $465 Million
- Q2 2025
A detailed history of Prestige Wealth Management Group LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 165 shares of ARWR stock, worth $5,933. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165
Previous 65
153.85%
Holding current value
$5,933
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
323Shares Held
99.6MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$564 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$558 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$381 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$229 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$188 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.81B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...